Fred Ramsdell

Q: What Schools Are Affiliated With Fred Ramsdell

Fred Ramsdell is affiliated with the following schools: University of California, San Diego, University of California, Los Angeles, Stanford University, University of California, San Francisco, Columbia University

Fred Ramsdell's AcademicInfluence.com Rankings

Fred Ramsdell

Biology

#8733

World Rank

#11860

Historical Rank

Immunology

#700

World Rank

#722

Historical Rank

biology Degrees

Download Badge

Biology

Fred Ramsdell's Degrees

PhD Immunology Stanford University
Doctorate Medicine Stanford University

Why Is Fred Ramsdell Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Frederick J. "Fred" Ramsdell is an American immunologist. Ramsdell graduated from the University of California, San Diego in 1983 with a bachelor's degree in biology and from the University of California, Los Angeles in 1987 with a Ph.D. in immunology. As a postdoc he worked at the National Institutes of Health and subsequently in biotech companies in the Seattle area. He has served as a senior executive at several biotech companies Darwin Molecular/Celltech, ZymoGenetics, Novo Nordisk, and aTyr Pharma. Since the beginning of 2016, he has been Research Director at the Parker Institute for Cancer Immunotherapy in San Francisco.

(See a Problem?)

Fred Ramsdell's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 (2001) (3339)
An essential role for Scurfin in CD4+CD25+ T regulatory cells (2003) (3059)
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse (2001) (2700)
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy (2001) (1918)
Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice (1994) (1698)
Fas ligand mediates activation-induced cell death in human T lymphocytes (1995) (1024)
Fas and FasL in the homeostatic regulation of immune responses. (1995) (622)
Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation* (2001) (574)
Fas transduces activation signals in normal human T lymphocytes (1993) (558)
The activation antigen CD69 (1994) (536)
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis1 (2006) (497)
Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. (1990) (386)
Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. (1994) (370)
Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV‐1‐regulated protein gp34. (1994) (317)
A nondeletional mechanism of thymic self tolerance. (1989) (316)
Foxp3 and natural regulatory T cells: key to a cell lineage? (2003) (310)
Vstm3 is a member of the CD28 family and an important modulator of T‐cell function (2011) (255)
A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome (2001) (237)
Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage (1991) (228)
Maintenance of in Vivo Tolerance by Persistence of Antigen (1992) (225)
Cellular and molecular characterization of the scurfy mouse mutant. (1999) (214)
FOXP3 and scurfy: how it all began (2014) (198)
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction (2020) (194)
The majority of CD4+8- thymocytes are functionally immature. (1991) (158)
gld/gld mice are unable to express a functional ligand for Fas (1994) (158)
The level of CD8 expression can determine the outcome of thymic selection (1992) (150)
Molecular characterization of the early activation antigen CD69: A type II membrane glycoprotein related to a family of natural killer cell activation antigens (1993) (146)
The mouse CD69 gene. Structure, expression, and mapping to the NK gene complex. (1994) (136)
CD40 ligand is a T cell growth factor (1993) (130)
The Amount of Scurfin Protein Determines Peripheral T Cell Number and Responsiveness1 (2001) (109)
Biology Direct (2006) (101)
Splice variants of human FOXP3 are functional inhibitors of human CD4+ T‐cell activation (2006) (97)
Recombinant CD40 ligand exerts potent biologic effects on T cells. (1994) (79)
Engagement of CD4 and CD8 accessory molecules is required for T cell maturation. (1989) (71)
Transcription factors in autoimmunity. (2003) (63)
A Novel Mutation in CD83 Results in the Development of a Unique Population of CD4+ T Cells (2004) (59)
Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes. (1988) (56)
Characterization of Foxp 3 CD 4 CD 25 and IL-10-Secreting CD 4 CD 25 T Cells during Cure of Colitis 1 (2006) (54)
A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic Protein 1 in lymphopoiesis and innate immunity (2008) (52)
Dynamic regulation of FoxP3 expression controls the balance between CD4+ T cell activation and cell death (2005) (47)
Generation of lymphokine-activated killer cell activity from human thymocytes. (1987) (46)
T-cell tolerance. (1993) (43)
Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef. (1993) (37)
A self-reactive T cell population that is not subject to negative selection. (1992) (35)
Identification of OX40 ligand and preliminary characterization of its activities on OX40 receptor. (1994) (30)
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again (2018) (29)
Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex. (1991) (28)
In Vitro Systems for the Study of T Cell Development: Fetal Thymus Organ Culture and OP9‐DL1 Cell Coculture (2006) (23)
CD40 ligand acts as a costimulatory signal for neonatal thymic gamma delta T cells. (1994) (21)
A forward-genetic approach for analysis of the immune system (2003) (20)
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art (2018) (18)
Scurfy, the Foxp3 locus, and the molecular basis of peripheral tolerance. (2008) (18)
Foxp3: a genetic foundation for regulatory T cell differentiation and function (2020) (14)
Similarities between LAK cells derived from human thymocytes and peripheral blood lymphocytes: expression of the NKH-1 and CD3 antigens. (1988) (13)
Generation of lymphokine-activated killer cell activity from non-NK precursor cells. (1988) (10)
A mouse strain defective for αβ versus γδ T cell lineage commitment (2002) (9)
Benzobicyclooctanes as novel inhibitors of TNF-α signaling (2002) (8)
Pillars Article: An Essential Role for Scurfin in CD4+CD25+ T Regulatory Cells. Nat. Immunol. 2003. 4: 337-342. (2017) (7)
Immunoregulatory effects of Fas‐mediated signalling (1996) (6)
Fetal Thymus Organ Culture for T Cell Development Studies (1992) (6)
You say tomato, I say tomato (2001) (6)
Role of proliferation in LAK cell development (2004) (6)
An approach to development of specific T-lymphocyte lines by use of preprocessed antigens in Plasmodium vinckei vinckei murine malaria (1993) (3)
A mouse strain defective for alphabeta versus gammadelta T cell lineage commitment. (2002) (3)
TNF abrogates the response of the CT.4S cell line to IL-4. (1994) (2)
Cure of Colitis T Cells during + CD25+ IL-10-Secreting CD4 and + CD25+ CD4+ Characterization of Foxp3 (2006) (2)
Benzobicyclooctanes as Novel Inhibitors of TNF-α Signaling. (2002) (1)
Benzobicyclooctanes as novel inhibitors of TNF-alpha signaling. (2002) (1)
Identification of a T cell immunomodulatory domain in histidyl-tRNA synthetase (2018) (1)
Opportunities for Treg cell therapy for the treatment of human disease (2023) (0)
IL-2-Induced Cytotoxic Cells From Human Thymocytes (2018) (0)
Identification and Characterization of Vstm3 as an inhibitory member of the CD28 family (90.31) (2009) (0)
Expression of NKH-1 and CD3 on Lymphokine-Activated Killer Cells Generated from Thymocytes (1989) (0)
T Cells +Development of a Unique Population of CD4 A Novel Mutation in CD83 Results in the (2004) (0)
Method of regulating the immune function in primates using the Foxp3 protein (2002) (0)
Thymic mechanisms for inducing tolerance to Mls. (1991) (0)
ResponsivenessPeripheral T Cell Number and The Amount of Scurfin Protein Determines (2001) (0)
Foxp3: a genetic foundation for regulatory T cell differentiation and function (2020) (0)
Abstract 3210: Strategies to improve the sensitivity and ranking ability of neoantigen prediction methods: Report on the results of the Tumor nEoantigen SeLection Alliance (TESLA) (2020) (0)
Table of Contents (1994) (0)
Human monoclonal anti-IL-21 (2008) (0)
Participation of CD4 and CD8 Accessory Molecules in the Development and Selection of T Lymphocytes (1989) (0)
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again (2018) (0)
Hem-1 is essential for hematopoietic cell development and function by regulating the actin cytoskeleton (138.8) (2009) (0)
Development of a large-scale H3.3K27M-specific TCR-transduced T cell manufacturing method for adoptive cell therapy in HLA-A2+ patients with diffuse midline glioma (2019) (0)

This paper list is powered by the following services:

Other Resources About Fred Ramsdell

en.wikipedia.org

What Schools Are Affiliated With Fred Ramsdell?

Fred Ramsdell is affiliated with the following schools:

Fred Ramsdell's Academic­Influence.com Rankings